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Abstract
TGFb and BMP signaling pathways exhibit antagonistic activities during the development of many tissues. Although the
crosstalk between BMP and TGFb signaling pathways is well established in bone development, the relationship between
these two pathways is less well defined during cartilage development and postnatal homeostasis. We generated
hypomorphic mouse models of cartilage-specific loss of BMP and TGFb signaling to assess the interaction of these pathways
in postnatal growth plate homeostasis. We further used the chondrogenic ATDC5 cell line to test effects of BMP and TGFb
signaling on each other’s downstream targets. We found that conditional deletion of Smad1 in chondrocytes resulted in a
shortening of the growth plate. The addition of Smad5 haploinsufficiency led to a more severe phenotype with shorter
prehypertrophic and hypertrophic zones and decreased chondrocyte proliferation. The opposite growth plate phenotype
was observed in a transgenic mouse model of decreased chondrocytic TGFb signaling that was generated by expressing a
dominant negative form of the TGFb receptor I (DTbRI) in cartilage. Histological analysis demonstrated elongated growth
plates with enhanced Ihh expression, as well as an increased proliferation rate with altered production of extracellular matrix
components. In contrast, in chondrogenic ATDC5 cells, TGFb was able to enhance BMP signaling, while BMP2 significantly
reduces levels of TGF signaling. In summary, our data demonstrate that during endochondral ossification, BMP and TGFb
signaling can have antagonistic effects on chondrocyte proliferation and differentiation in vivo. We also found evidence of
direct interaction between the two signaling pathways in a cell model of chondrogenesis in vitro.
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Introduction
The transforming growth factor b (TGFb) superfamily is a large
group of secreted polypeptides, including TGFb1, 2, 3, activins,
inhibins and nodal, bone morphogenetic proteins (BMPs) and
growth differentiation factors (GDFs). TGFb family members are
vitally important during embryogenesis, as well as in the
homeostasis in the adult tissues. These molecules are also involved
in the regulation of cellular processes such as proliferation,
differentiation and apoptosis.
The Smad-dependent TGFb and BMP signaling pathways have
been well established for decades. TGFb or BMP ligands bind to
specific type II receptors to recruit the corresponding type I
receptor to initiate a cascade of events leading to phosphorylation
of their specific receptor-Smads (R-Smads). Generally, TGFb
signaling depends on Smad2 and Smad3, while BMP signaling
depends on Smad1, 5 and 8. The phosphorylated R-Smad forms a
heterocomplex with the Smad4, the common partner Smad (Co-
Smad). The R-Smad/Co-Smad complex then translocates into the
nucleus, where it binds to promoters of target genes and regulates
their transcription [1]. Besides, TGFb/BMP signaling can also be
mediated by noncanonical MAPK pathways, such as P38, JNK
and Erk1/2 signaling pathways, during chondrogenesis [2].
BMPs play an important role in the earliest stages of
chondrogenesis, i.e. mesenchyme condensation and cell fate
determination. In vitro BMPs can promote mesenchymal cells to
differentiate into chondrocytes in high-density cultures [3] in part
by inducing Sox9 gene expression [4]. Not surprisingly, BMP
signaling components are highly expressed in growth plates with
specific temporal-spatial patterns that correlate with functions
during growth plate development and homeostasis. [5,6,7,8,9,10].
For example, BMPs play an important role in regulating the
proliferation of chondrocytes. Loss of Noggin, a potent BMP
antagonist, leads to overgrowth of skeletal elements in mice [11].
On the other hand, misexpression of Noggin in chick limbs causes
reduction in of skeletal elements [6]. Moreover, BMPs promote
the differentiation of proliferating chondrocytes to hypertrophic
chondrocytes, the chondrocyte specific expression of constitutively
active Bmpr-1a in transgenic mice accelerated the maturation and
hypertrophy of proliferating chondrocytes [12]. Recently, Retting
et al. showed that the complete loss of Smad1 and Smad5 in
chondrocytes leads to a severe chondrodysplasia and that both
mediators have overlapping functions in the developing growth
plate. However, only one copy of either Smad1 or Smad5 is
sufficient to correct the chondrodysplasia seen in the chondrocyte
specific Smad1
2/2/Smad5
2/2 growth plate [13].
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demonstrated in various models. TGFb1, 2 and 3 are expressed in
the mouse perichondrium and periosteum from E13.5 until after
birth [14,15,16,17,18], while TGFb receptors are expressed in
perichondrium and in chondrocytes [19]. The growth plate of
Smad3
2/2 mice exhibits the formation of large osteophytes,
decreased production of proteoglycans. Moreover, the Smad3
2/2
mice develop degenerative joint disease resembling human
osteoarthritis, featuring an increased expression of Collagen X in
the chondrocytes of synovial joints [20]. Additionally, the
conditional deletion of the TgfbrII with Col2a1-Cre and Prx1-Cre
causes axial skeleton defects, alteration in hypertrophic differen-
tiation in growth plates, and joint fusions in phalanges [21,22],
supporting a role of the TGFb signaling pathway in both axial and
appendicular bone and joint formation.
To further understand the role of BMP and TGFb signaling in
the postnatal growth plate and to elucidate potential crosstalk
between both signaling pathways we generated and compared two
mouse models with partial deficiency of either BMP or TGFb
signaling in the growth plate. Our findings showed that while
reduced BMP signaling in proliferating chondrocytes leads to a
shortening of the growth plate in part due to decreased cell
proliferation, reduced TGFb signaling results in an increased
proliferation rate and an elongated growth plate. We also identify
an interesting interaction between these two signaling pathways in
a cell model of chondrogenesis.
Results
Smad1
cKO/cKO mice show shortened growth plate
In the epiphyseal growth plate, Smad1 is strongly expressed in
proliferating chondrocytes [23]. Smad1 null mice (Smad1
2/2)d i e
by 10.5 days post coitum (dpc) from defects in morphogenesis and
proliferation of extra-embryonic tissue [24]. Therefore to analyze
the Smad1 function in cartilage we used a conditional knockout
strategy to specifically delete Smad1 in the growth plate by
crossing mice with a floxed Smad1 allele to transgenic mice
carrying Cre recombinase driven by the type II collagen promoter
(Col2a1-cre) [25]. To determine the efficiency of the Smad1
deletion, DNA extracted from mouse tail or ribcage was used as
template in a PCR with primers flanking the two loxP sites. A
350 bp product specific for the Smad1 deletion confirmed the in
vivo efficiency of Cre-mediated recombination in cartilage
(Figure S1B).
To further verify that the conditional deletion was achieved,
semiquantitative RT-PCR was performed using cDNA generated
from P1 rib cartilage RNA (Figure S1C). Smad1 expression was
only observed in controls but not in the cartilage of Smad1
cKO/cKO
mice, indicating that Smad1 is effectively deleted in proliferating
chondrocytes. Due to the redundancy of Smad1 and Smad5
expression and function, these mice were further bred with
Smad5
+/2 heterozygous mice to incrementally decrease overall
BMP/Smad-signaling. Because of the embryonic lethality of
Smad5
2/2 mice, we did not further generate Smad
cKO/cKO;
Smad5
2/2 mice so that we could study the postnatal phenotype in
detail. Also it is now known that a conditional KO of Smad1 and
Smad5 in chondrocytes leads to severe chondrodysplasia [13] and
this approach enabled us to study subtle alterations in signaling
during development and homeostasis. We were unable to detect
any significant differences between WT, Smad1
cKO/cKO and
Smad1
cKO/cKO;Smad5
+/2 mice by weight measurements (data not
shown). Skeletal preparations with Alcian Blue and Alizarin Red
staining showed no patterning defects in these mice (data not
shown).
Althoughthe Smad1
cKO/cKOand Smad1
cKO/cKO;Smad5
+/2miceshow
no gross growth phenotypes, to evaluate a subtle growth plate
phenotype we next analyzed the long bone of these mice by a
histological evaluation (Figure 1A–C). In P1 mice, our analysis
demonstrated a significantly shortened growth plate in Smad1
cKO/cKO
mice (168.2+/214.4 mm), and for Smad1
cKO/cKO;Smad5
+/2 (136.8
+/214.5 mm) vs. WT littermates (186.3+/221.5 mm) (Figure 1G).
ThisresultsuggestedadosagerequirementforBMP/Smadsignaling
during growth plate development. In eight weeks old adult mice, we
observed similarly shortened growth plates in Smad1
cKO/cKO and
Smad1
cKO/cKO;Smad5
+/2 mice supporting a continued postnatal
requirement in postnatal growth plates (Figure 1D–F). To test
whether the deletion of the Smad1 and Smad5 allele in cartilage can
leads to a decreased response to BMP signaling, we detected
pSmad1,5 level by Western blots in the rhBMP2 treated primary
chondrocytesderivedfromSmad1
cKO/cKO and Smad1
cKO/cKO;Smad5
+/2
mice. As predicted, a distinctive decrease of pSmad1,5 level were
detected in Smad1
cKO/cKO chondrocytes, and the decreases is more
pronounced in Smad1
cKO/cKO;Smad5
+/2 mice, suggesting that lost of
Smad1 and Smad5 allele effectively inhibit BMP canonic signaling
(Figure 1H).
Smad1
cKO/cKO;Smad5
+/2 mice show no significant
differentiation defect but decreased proliferation in
chondrocytes
To corroborate the reduced length of the prehypertrophic and
hypertrophic zones, in situ hybridization for Ihh and col10a1 was
performed on hind limb sections, respectively. We found that both of
the prehypertrophic and the hypertrophic zones in Smad1
cKO/cKO;
Smad5
+/2mice were shortened and that Ihh expressionwas reduced in
comparison to the wild type control mice (Figure 2A–F). By
quantitative real time PCR, we observed a trend of decreased
expression of Ihh and Col10al (data not shown). We further performed
SafraninO staining as a qualitative assessment of extracellular matrix
(ECM) but were unable to detect significant differences in ECM
content in Smad1
cKO/cKO or Smad1
cKO/cKO;Smad5
+/2 mice (data not
shown). These data suggest that a single allele of Smad5 was sufficient
to maintain the differentiation program of chondrocytes, while per
previous report, complete loss of Smad1 and Smad 5 in cartilage led to a
severe chondrodysplasia with altered chondrocyte differentiation [13].
To understand whether the changes in chondrocyte prolifera-
tion contribute to the aforementioned growth plate phenotype in
these animal models, we performed a BrdU incorporation assay to
determine the proliferation status of Smad1
cko/cko and Smad1
cko/cko;
Smad5
+/2 mice. In the femurs of P1 Smad1
cKO/cKO;Smad5
+/2 mice,
proliferation of chondrocytes was significantly reduced by 23.4%
compared to wild type controls, while chondrocyte proliferation of
Smad1
cKO/cKO mice was also decreased by 17.3% compared WT
mice. (Figure 2 G–I). Hence the severity of the proliferative
defect was inversely correlated with the number of Smad1 and
Smad5 alleles remaining in cartilage.
Col2a1-DTbRI transgenic mice exhibit an elongated
growth plate
To study loss of function or impaired function of TGFb signaling
in the growth plate we generated transgenic mice that overexpress
thedominant negative TGFb receptortypeI (DTbRI) specificallyin
proliferating chondrocytes by the Collagen 2a1 (Col2a1) promoter.
The DTbRI is a truncated protein, retaining the ligand binding
domain and the transmembrane domain, but lacking the activating
serine/threonine kinase domain. Therefore, it can competitively
bind to TGFb ligands to act in a dominant negative fashion on wild
type receptor-ligand interactions. In this manner, it acts as a decoy
TGFb and BMP Pathways during Chondrogenesis
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prevents the ligands’ access to a functional receptor complex,
thereby blocking TGFb signaling (Figure S2A). Three founder
mice were obtained (Figure S2B); the two founders with the
highest expression were used to establish lines for phenotypic
studies.
By Alcian blue and Alizarin red staining of the skeletons, a mild
reduction in the size of the skeleton (data not shown) was noted,
but there were no patterning defects observed in the P1 transgenic
mice. Consistent with the smaller skeletal size, newborn transgenic
mice demonstrated a statistically significant lower weight as
compared with their wild type littermates (data not shown).
Interestingly, in contrast to the loss of BMP signaling model, the
growth plates of mice carrying the Col2a1-DTbRI construct were
slightly elongated at P1 (Figure 3 A–C) and at 4 weeks (Figure
S2C and D). To test whether the overexpression of DTbRI in
cartilage can leads to a decreased response to TGFb signaling, we
detected pSmad2, and pSmad3 levels by Western blots in the
rhTGFb1 treated primary chondrocytes derived from Col2a1-
DTbRI Tg mice. The result showed a distinctive decrease of
pSmad2 and pSmad3 levels in the Tg chondrocytes, suggesting
that DTbRI acts dominant-negatively and can effectively inhibit
TGFb canonic signaling (Figure 1H).
Col2a1-DTbRI transgenic mice show expanded
prehypertrophic zone and increased chondrocytes
proliferation
To further characterize the elongated growth plate phenotype
in Col2a1-DTbR1 transgenic mice, we evaluated markers of
chondrocytes differentiation by in situ hybridization. We were
Figure 1. Shortened and disorganized growth plate in mice with disrupted BMP signaling. (A–C) Growth plate sections of long bones of
P1 and (D–F) eight weeks old mice stained with Hematoxylin and Eosin. (G) Quantification of growth plate length (3 data points in each 20 sections of
two mice per genotype, P=,0.001). cKO: conditional knock out; um: micrometer; WT: wild type. (H) Compared to WT control, Smad1
cKO/cKO and
Smad1
cKO/cKO;Smad5
+/2 primary chondrocytes exhibit blunted response to rhBMP2 treatment, as revealed by decreased pSmad1,5 levels in the
Western blots. a-tubulin is used as loading control.
doi:10.1371/journal.pone.0016421.g001
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zone-specific Col10a1 probe (Figure 3 J and K). However, the Ihh
positive prehypertrophic zone was expanded in the transgenic
mice (Figure 3 L and M). Moreover, the intensity of Ihh
hybridization signal was qualitatively increased in the transgenic
growth plate. We cannot exclude that the lack of phenotype in the
hypertrophic zone might be due to lack of expression of the
transgene in this region given that the Col2a1 promoter is inactive
here.
We next evaluated the change of chondrocyte proliferation in
the proliferating zone by BrdU incorporation assay. The Col2a1-
DTbRI transgenic mice exhibit increased proliferation in chon-
drocytes compared to WT controls (p,0.005, Figure 3E–F).
Here, we found that decreased TGFb signaling in vivo led to
increased chondrocyte proliferation, suggesting that TGFb
signaling is an inhibitor of proliferation of chondrocytes at least
in this context.
Because TGFb signaling is a key regulator of ECM synthesis
and deposition, we next performed Safranin O staining on distal
femurs in wild type controls, heterozygous, and homozygous
Col2a1-DTbRI mice. We found that in the transgenic mice, ECM
was remarkably decreased (Figure 3 A–D). At the same time, the
cellular density of proliferating chondrocytes was also significantly
increased consistent with the increase in chondrocyte proliferation.
BMP2 can inhibit TGFb signaling, while TGFb1 enhances
BMP signaling in-vitro
The interaction between BMP and TGFb signaling has been
known to be a critical determinant of various programs of
organogenesis and homeostasis. The output of this crosstalk is
complex and context dependent due to the fact that BMP and
TGFb can be antagonistic in some tissues, but synergistic in others
[26,27,28]. Abundant published data support the importance of
BMP and TGFb as regulators in chondrogenesis and growth plate
homeostasis [29,30]. However, direct interaction of these two
signaling pathways has not been clearly studied in cartilage.
Hence, we attempted to further study this issue using an in vitro
model of chondrogenesis, i.e., the ATCD5 rat chondrogenic cell
line. Using BMP and TGFb responsive luciferase reporter
constructs (ld1- or SBE-Luciferase respectively) we evaluated the
effects of combined BMP and TGFb ligand on transfected,
undifferentiated ATDC5 cells. After serum starvation and
treatment 8 hours with human recombinant BMP and/or TGFb
(rhBMP, rhTGFb respectively), cells were harvested for luciferase
activity assay and Western blots.
Both reporter systems responded respectively to BMP or TGFb
treatment and we found that the rhTGFb1 treatment alone could
not activate the BMP reporter. Similarly, treatment with
recombinant BMP2 alone was not able to induce TGFb reporter.
But interestingly, TGFb1 and BMP2 co-treatment led to an
elevated BMP reporter activity when compared with the same
amount of BMP2 alone. Moreover, this co-treatment was able to
repress TGFb signaling significantly in comparison to treatment
with TGFb alone (Figure 4 A and C). These effects were dose
responsive for both BMP2 (30, 300 or 600 ng/well) and TGFb (2,
10 or 20 ng/well) concentration. These results were independently
confirmed by western blots for p-Smad1/5/8 and p-Smad2 on the
cell lysate, with total Smads1/5/8 and Smad2 as controls
(Figure 4 B and D).
Discussion
The focus of this work has been compare the effects of BMP and
TGFb signaling and interactions in chondrocytes and in postnatal
cartilage. The essential requirements for these respective pathways
have been successfully generated by strong loss of function
phenotypes. However, because of early lethality of complete loss
of signaling models, it was difficult to assess their requirements
postnatally during homeostasis. To circumvent this problem, we
generated incremental deletions of Smad1 and Smad5 to achieve a
Figure 2. Decreased chondrocytes proliferation, shortening of
pre-hypertrophic and hypertrophic zone in BMP signaling
deficient mice. Shortened prehypertrophic and hypertrophic zone
due to decreased proliferation in Smad1
cKO/cKO;Smad5
+/2 mice com-
pared to WT control. (A and B) Hematoxylin and Eosin staining, In-situ
hybridization with (C and D) Col10a1 and (E and F) Ihh probes showed
that both the hypertrophic and prehypertrophic zone are shorter in
Smad1
cKO/cKO;Smad5
+/2 mice compared to WT control (indicated by
white bars in each panel). (G–I) BrdU staining revealed a decreased
proliferation rate in Smad1
cKO/cKO;Smad5
+/2 compared to WT control
(P,0.02).
doi:10.1371/journal.pone.0016421.g002
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data showed that a single allele of Smad5 was sufficient to
maintain postnatal growth and skeletal development suggesting
that the wild type expression of Smad1 or Smad5 alone may not be
the rate limiting step of BMP signal transduction. This also
supports strong functional redundancy between Smad1 and
Smad5 during chondrogenesis. However, when we looked closely
at the growth plate phenotype, we observed a shortened and
mildly disorganized growth plate in the Smad1
cKO/cKO and
Smad1
cKO/cKO;Smad5
+/2 mice. This showed that by sequentially
reducing total BMP-specific R-Smads, we were able to attenuate
BMP signaling sufficiently to affect growth plate development and
homeostasis while also elucidating an underlying cellular defect.
Based on the recent published data by Retting et. al., complete
deletion of Smad1 and Smad5 in chondrocytes leads to a dramatic
lethal chondrodysplasia, suggesting a critical requirement of
Smad1 and Smad5 during development [13]. In our studies, the
mouse models of partial depletion of BMP signaling did not
produce a strong chondrodysplasia enabling us the opportunity to
study effects of loss of BMP function in adult animals and to
Figure 3. Col2a1-DTbR1 transgenic mice exhibits elongated growth plate and increased proliferation of chondrocytes. Longer
prehypertrophic zone, defective ECM production, and increased proliferation can be observed in Col2a1-DTbR1 mice. Safranin O staining of (A) WT
control and (B) the Col2a1-DTbR1 mice (TG) shows a slight lengthening of the growth plate in the TG animals as well as a significantly impaired
extracellular matrix production. (C–D) Also, a higher cell density in TG proliferating zone is detected. (E–G) TG proliferating zone exhibits increased
BrdU positive cells compared to WT control (*P value=0.02). While in-situ hybridization with Col10a1 (J and K) does not show an increase in the size of
the hypertrophic zone, in-situ hybridization with a probe for Ihh (L and M) demonstrates an elongation of the prehypertrophic zone (indicated by
white bars in each panel). (H and I) Consecutive sections stained with Hematoxylin and Eosin. (N) Compared to WT control, Col2a1-DTbR1 primary
chondrocytes exhibit blunted response to to rhTGFb1 treatment, revealed by decreased pSmad2 and pSmad3 levels in the Western blots. a-tubulin is
used as loading control.
doi:10.1371/journal.pone.0016421.g003
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developmental stages.
Our study showed that the decreased proliferation in the
Smad1
cKO/cKO or Smad1
cKO/cKO;Smad5
+/2 proliferating chondro-
cytes contributes to the shortened postnatal growth plate.
Canonical BMP signals can promote proliferation and differenti-
ation in prehypertrophic chondrocytes, leading to the expression
of Ihh in the prehypertrophic zone. Ihh then signals back via Ptc
and Gli, leading to the expression of PTHrP, which in turn is able
to keep chondrocytes in the proliferative pool [5,31]. These data
suggest that the disrupted BMP signaling in proliferating
chondrocytes of the Smad1
cKO/cKO or Smad1
cKO/cKO;Smad5
+/2
mice inhibits proliferating chondrocytes differentiating to pre-
hypertrophic chondrocytes. The observed proliferative phenotype
may be related to down regulated PTHrP. One limitation of this
approach is the lack of direct effect on potential Smads
independent BMP signaling. But our and Retting et. al.’s findings
suggest that MAPK pathway may not be essential for chondrocyte
differentiation and maturation [13], since only one copy of Smad1
or 5 is enough to conserve an almost normal phenotype. The
complete knock out of the canonical arm of the pathway leads to
severe chondrodysplasia even though the non-canonical pathway
is completely intact in this model.
The importance of TGFb signaling during chondrogenesis and
homeostasis has also been studied for decades but the conclusions
of these studies have differed depending on the studies or disease
models. This reflects the complex context-dependent regulation of
TGFb at both tissue and cellular levels. TbRI and TbRII are
highly expressed in proliferating and maturing chondrocytes as
well as the perichondrium in the growth plate [19]. To study the
role of TGFb signaling in the proliferating chondrocytes, we
generated a transgenic mouse overexpressing a dominant-negative
form of the TbRI to disrupt TGFb signaling early in the
differentiation program [32,33]. Due to the high turn over rate of
TGFb receptors through rapid internalization and ubiquitin-
dependent downregulation [34], we expect that the dominant-
negative TbRI is predominantly expressed in proliferating
chondorcytes and not in the hypertrophic chondrocytes. Our in
vivo studies revealed that depletion of the TGFb specific pathway
leads to an overall longer growth plate due to an elongated
proliferating zone and expanded Ihh positive prehypertrophic
zone. We further detected significantly increased proliferation of
chondrocytes and decreased extracellular matrix deposition in the
proliferating zone of the transgenic mice. These data suggest that
TGFb signaling inhibits proliferation as well as the initiation of
hypertrophy of chondrocytes.
Our finding is in line with some earlier studies. Mice that
express a dominant negative TGFb receptor type II under the
control of a metallothionein promoter in skeletal tissues showed
severe skeletal defects, including a disorganized growth plate with
a prolonged prehypertrophic and hypertrophic zone [35]. The E-
Selectin ligand-1 (ESL-1) knockout mice exhibit higher TGFb
bioavailability, and show shortened growth plate and growth
retardation [36]. Moreover, Ltbp-3 null mice, which show
decreased TGFb bioavailability in the skeleton, display both wider
zone of prehypertrophic and hypertrophic zones in synchondrosis
compared to wild type littermates [37]. Because the Col2a1
promoter in our mice is not expressed in the hypertrophic
chondrocytes, and the high tune over rate of TGFb receptors, a
notable phenotype in the hypertrophic zone is not detected.
The overlapping expression patterns of the BMP and TGFb
receptors, ligands and Smads suggest a potential interaction
between BMP and TGFb signaling in the developing and
postnatal growth plate. To understand this possible interaction
Figure 4. Mutual regulation between BMP and TGFb signaling
pathways in ATDC5 cells. In ATDC5 cells, TGFb is able to enhance
BMP signaling, while BMP2 has an antagonistic effect on TGFb
signaling. (A) The Id1-Luciferase reporter is significantly activated by
different amounts of human recombinant (hr) BMP2 (30, 300 and
600 ng). The addition of hrTGFb1 (0.5, 2 or 20 ng) leads to further
increase in the luciferase activity. (B) Western Blot with BMP specific
phospho-Smad1/5/8 confirmed the results. The amount of total
Smad1of all samples under any treatment scheme is not significantly
changed. (C) SBE-Luciferase reporter is significantly activated by
different amount of rhTGFb, while the addition of BMP2 decreases
the overall TGFb activity. (D) Western Blot using phospho-Smad2
antibody confirmed these results.
doi:10.1371/journal.pone.0016421.g004
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with hrBMP2 and/or hrTGFb1. The results showed that TGFb1
significantly enhances BMP signaling, while in contrast, BMP2
inhibited TGFb signaling. The negative regulatory role of BMP in
TGFb signaling has been demonstrated in several models, for
example in the murine model systems for kidney disease [38] and
in mouse pulmonary myofibroblast [39]. One explanation might
be the competitive occupation of common downstream effectors
such as Smad4. We detected a similar degree of Smad4 expression
in treatment combinations (data not shown), but competitive
inhibition would not necessarily change the total amount of
Smad4. Another explanation could be that the induction of
inhibitory Smad6 or Smad7 by BMP2 leads to the inhibition of the
TGFb signaling pathway, but again we could not detect any
obvious differences in Smad6 and Smad7 protein levels (Data not
shown). These data would suggest that the crosstalk between BMP
and TGFb signaling pathways in chondrogenic cells may depend
on other mechanisms. Another possibility may also be the
differential effects of canonical vs. noncanonical signaling in the
specification of a cellular phenotype.
TGFb acting as an activator of BMP signaling in chondrogenic
cells is surprising to us, because it contradicted what has been
established in osteogenic cell experiments. It has been reported
that BMPs can promote expression of osteoblast differentiation
markers in MC3T3 cells and lead to mineralization [40].
However, TGFb1 cannot induce the expression of these
osteogenic markers, but inhibits expression of osteocalcin and
alkaline phosphatase stimulated by BMP2 treatment [40]. Another
study showed that BMP3 and TGFb1 have antagonistic effects on
both proliferation and differentiation of human bone marrow
stromal cells [41]. Moreover, BMP 2 was found to be able to
induce osteogenic and chondrogenic phenotypes in adipocyte stem
cells, which can be inhibited by the simultaneous TGFb1
treatment [42].
However, in some other cell model systems, TGFb was
identified as acting synergistically with BMP signaling. For
example, TGFb can directly induce Smad1 phosphorylation in
endothelial cells, by forming complexes between TbRII and
ALK1, thus leading to stimulation of cell proliferation and
migration [27]. Besides, TGFb induced Smad1 phosphorylation
was also identified in the C2C12 cells, keratinocytes, MEFs and
HepG2 cells, suggesting that the synergetic effect of TGFb on
BMP signaling may exist in many other tissues during tissue
development and homeostasis [27]. We expect that a similar
signaling crosstalk may also be present in the chondrogenic cells. It
is worthy to mention that in our experiment, TGFb treatment
alone could not induce Smad1 phosphorylation in the ATDC5
culture. This suggests that BMP may be required to potentiate a
cellular context for the ATDC5, which allows TGFb to stimulate
Smad1 phosphorylation. For example, this potentiation may
produce specific receptor complex or other signaling components
that are required for TGFb to stimulate Smad1 activation. This
aspect is of considerable interest and deserves further studies.
Overall, this study provides new insight into the interaction of
BMP and TGFb signaling during growth plate homeostasis and
endochondral ossification. Moreover, we found evidence for a
crosstalk between these two signaling pathways, which differs from
that as identified in bone. BMP2 is able to inhibit TGFb1
signaling, while TGFb1 can significantly increase BMP2 signaling
in chondrocytes in vitro. Why the growth plate might be in need of
such a signaling feedback loop is still puzzling. It is somewhat
similar to the Ihh/PTHrP signaling loop, where Ihh promotes
PTHrP expression while PTHrP suppresses Ihh expression. This
Ihh/PTHrP feedback loop helps to define the balance between
proliferating and hypertrophic cells and regulates the temporal
progression of endochondral ossification in the growth plate.
Whether the BMP/TGFb feedback loop we identified in the
chondrogenic cell line acts by a similar mechanism remains to be
further studied. It may act in part to regulate proliferation in the
context of such a negative feedback loop.
Materials and Methods
Ethics Statement
Handling and euthanization of mice for the following
experiments was carried out in compliance with federal laws and
regulations. The protocol was approved by the Institutional
Animal Care and Use Committee (IACUC, Permit Number:
AN1506) at Baylor College of Medicine.
Generation of TG mouse line, breeding and genotyping
Smad1 conditional knock out mice were obtained from Dr. E.
Robertson [24]. The Smad1 conditional allele was detected by
PCR using a primer pair flanking the second loxP-site (F: 5-GTC
ATC TCC TTC TCG TAC AG-3, R: 5-GGC CTT TAC TTT
CTC GTG AC-3). The PCR was performed on tail-DNA of adult
mice or DNA from skin of newborn mice. The Smad5 null mice
were obtained by Dr. A. Zwijsen and were genotyped as described
before [43]. The transgenic mice expressing Cre recombinase under
the control of the col2a1 promoter were obtained from Dr. R
Behringer and the genotyping was performed as described before
[25].
The dominant negative TbRI mice were generated by cloning
of the truncated cDNA of the ALK5 under the control of the 6 kb
col2a1 promoter (Col2a1-DTbR1) [44]. A Tyrosinase cassette was
used for visual genotyping [45], and a WPRE regulatory element
at the 39 end of the cDNA was included to enhance the expression
of the transgenic protein [46]. The genotype was verified using
primers specific for WPRE sequence (F:5-TCT CTT TAT GAG
GAG TTG TGG CCC-3; R: 5-ACT GAC AAT TCC GTG
GTG TTG TCG-3). Three different founders were generated.
Histology, von Kossa staining, SafraninO staining, RNA in-
situ hybridisation (ISH), and BrdU incorporation assay
For histological analysis, limbs from 8 week old mice were fixed
in formalin for 48 h. Decalcification was performed for 14 days in
10% EDTA (pH 7.2) at room temperature. Limbs of P1 mice were
fixed with 4% PFA overnight. All samples were embedded in
paraffin and sectioned at 5 mm thickness. The RNA in-situ
hybridization was performed as described previously [47]. For
the BrdU (Bromodeoxyuridine, Invitrogen) incorporation assay,
P1 mice were injected with BrdU (50 mg/g body weight, IP) and
sacrificed after 2 h. BrdU-Alexa-488 antibody (Invitrogen) was
used to detect the incorporated BrdU.
The length of the growth plate was measured using established
histomorphometric markers. Specifically, each femur section was
measured at three positions: two at the edges one in the center.
The starting point was set at the boundary between the round
chondrocytes and flat chondrocytes, and the end point was chosen
at the onset of mineralization (as shown in Figure S1D)[48]. 20
sections per mouse and two mice each phenotype was measured
blindly.
Primary Chondrocyte culture and ligand treatments
Ribs cages are isolated from P3 mice, and incubate with Ponase
(2 mg/ml in PBS) at 37uC for 30 min to remove the attached soft
tissues. The bony tissue from the rib cage is subsequently removed
by digestion in collagenase D (3 mg/ml in a-MEM) for 2 hours.
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D (1.5 mg/ml) with 5% fetal bovine serum. The dissociated
chondrocytes are washed by PBS and culture in 3.5 cm cell culture
dishes at 1610
6/dishes. After 24 hours, when the cell reach 70%
confluency, 100 ng/ml rhBMP2 or 2 ng/ml rhTGFb1 are added
to the culture. The chondrocytes are lysed in 1 x lamellae buffer
and subjected to Western blots.
DNA transfection and reporter assays
ATDC5 cells were cultured in a 1:1 mixture of Dulbecco’s
modified eagles medium and Hams F12-Medium (DMEM/F-12)
containing 5% fetal bovine serum (FBS), 10 ug/ml human
Transferrin, and 3610
28 M sodium selenite. Transfections were
done using Fugene6 (Roche) as transfection reagent. 0.4 mgo f
BMP-luciferase reporter (Id1-luc) or TGFb-luciferase reporter
(SBE-Luc) was used each well. All wells were co-transfected with
0.1 mg of a TK-Renilla luciferase plasmid (Promega) as an internal
transfection control. Six hours after transfection, the transfection
medium was replaced with serum starved medium. The following
day, 30–600 ng recombinant hBMP2 (R&D systems) or 2–20 ng
recombinant hTGFb1 (R&D systems) was added and incubated for
8 hrs. The luciferase assay was performed using the Dual Luciferase
Reporter Assay System (Promega). Data represent the average
ratios of Firefly-luciferase to TK-Renilla-luciferase activity.
Western Blot
Protein from cells was isolated using lysis buffer containing
100 mM potassium phosphate with 0.1% Triton X. A standard
western blot was performed using the following polyclonal
antibodies: anti-pSmad1,5,8 (1:1000, Cell signaling), anti-pSmad2
(1:1000, Cell Signaling), anti-total Smad2 (1:1000, Zymed) anti-
total Smad1 (1:1000, Invitrogen) and anti- a-tubulin monoclonal
antibody (1:5000, Sigma). The blots were subsequently incubated
in Peroxidase-conjugated secondary antibodies (anti-rabbit IgG,
1:5000, GE Healthcare UK Limited; or anti-mouse IgG, 1:5000,
Bio-Rad), and visualized by ECL reagents(Amersham Biosciences)
and X-film (Kodak) autography.
Statistical analysis
Data are expressed as mean values +/2 standard deviation.
Statistical significance was determined using Student’s t test and
data were considered statistically significant with a P value,0.05.
Supporting Information
Figure S1 Smad1 is specifically and effectively deleted in
Chondrocytes. (A) Schematic drawing of the Smad1 gene locus
and PCR genotyping strategy. (B) Genotyping PCR with primer
pair P1/P2 (B-i), the product size on WT DNA is 140 bp, with
incorporated loxP site the PCR product is 190 bp. On DNA of
heterozygous animals we detected a third product of 220 bp.
Sequencing showed that it is a heteroduplex of the two described
products. Genotyping PCR for Cre recombinase locus (product size
500 bp, B-ii) and PCR on cartilage DNA with primer pair P3/P2
(product size 350 bp, B-iii) showing that the part between the loxP
sites is effectively floxed out by Cre recombinase. (C) Semiquan-
titative RT-PCR on rib cartilage cDNA. cDNA from an animal
negative for the Cre recombinase allele is marked as -. cDNA from an
animal carrying the expressing Cre recombinase is marked as +.A s
expected, the expression of Smad1 in animals carrying the Cre
recombinase allele is very low compared to the wt control. Smad1 is
almost completely floxed out, the faint product could result from
contamination with cells, which are not expressing Cre recombinase.
(D) Quantification of growth plate length of WT, Smad1
fl/f,l and
Smad1
fl/fl;Smad5
+/2mice. Three measure points (marked with 1,2
and 3) in the growth plate were used to determine the length of the
growth plate. Starting point was set at the boundary between the
round chondrocytes and flat chondrocytes, and the end point was
chosen at the onset of mineralization. bp: base pair; fl: floxed; P:
Primer.
(TIF)
Figure S2 Transgenic overexpression of the dominant-negative
TGFb receptor type I (DTbRI) specifically in chondrocytes leads to
elongated growth plate. (A) Transgenic construct used to generate
transgenic mice. The Tyrosinase mini gene was used for coat color
genotyping. A woodchuck hepatitis virus posttranscriptional
regulatory element (WPRE) followed by the human growth
hormone polyadenylation signal (hGHpA) was added to increase
the transcription efficiency. Two HS4 chicken insulators were
added for preventing the unspecific expression influenced by
flanking genomic sequence. (B) Detection of TGFb receptor type I
over expressions levels in the rib cartilage of three established TG
lines using quantitative real-time PCR. (C and D) The phenotype
of elongated growth plate still remains in four weeks old transgenic
mice by Hematoxylin and Eosin staining. Col2a1: Collagen type II;
hGHpA: human growth hormone polyadenylation signal; HS4:
2x1.2-kb insulator element derived from the chicken beta-globin
locus; TG: Transgenic; Tyr: Tyrosinase mini gene; WPRE:
woodchuck hepatitis virus posttranscriptional regulatory element;
WT: wild type.
(TIF)
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